flutiform is indicated for the regular treatment of asthma and is available in low and medium strengths for patients aged 12 years or over and high strength for patients aged 18 years or over.1

1. flutiform Summary of Product Characteristics. 2015

You are now leaving and moving to an external website independently operated and not managed by Mundipharma International Ltd. Mundipharma International Ltd assumes no responsibility for the site or its content.

If you do not wish to leave this site, click Cancel or click OK to continue.

OK Cancel